Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Amarin Corp Ads
(NQ:
AMRN
)
5.020
USD
+0.010 (+0.20%)
Streaming Delayed Price
Updated: 8:00 AM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Amarin Corp Ads
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
4 Reasons Amarin Stock Could Tumble Even Further
August 05, 2020
The company's second-quarter earnings report was less than encouraging.
Tags
Market News
AMRN
From
Motley Fool
US Stocks That Surged Higher This Week: $AMRN $NAK $AGEN
August 05, 2020
Tags
The Market Signal
From
The Market Signal
Market Briefing For Wednesday, August 5
August 05, 2020
The pandemic is not over. There is also an epidemic of violence by those who do not grasp the importance of both freedom of expression, free-market capitalism, and what some allege is now...
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Amarin (AMRN) Q2 2020 Earnings Call Transcript
August 04, 2020
AMRN earnings call for the period ending June 30, 2020.
Tags
Market News
AMRN
From
Motley Fool
Amarin Reports Mixed Q2 As COVID-19 Weighs On Results; Analyst Sees Favorable Risk-Reward
August 04, 2020
Amarin Corporation plc (NASDAQ: AMRN) shares were advancing strongly Tuesday following the release Tuesday ofsecond-quarter ...
Tags
Biotech
Analyst Color
Price Target
From
Benzinga
Amarin's Vascepa Sales Jump 34% in Q2 Despite COVID-19 Headwinds
August 04, 2020
The big wild card for the company now is its appeal of a court ruling invalidating key patents for the high triglyceride drug.
Tags
Market News
AMRN
From
Motley Fool
The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans
August 04, 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) ABIOMED, Inc. (NASDAQ: ABMD) ALX Oncology Holdings Inc ...
Tags
NBIX
Trading Ideas
MYOK
From
Benzinga
Recap: Amarin Q2 Earnings
August 04, 2020
Shares of Amarin Corp (NASDAQ:AMRN) rose 2.2% in pre-market trading after the company reported Q2 results. Quarterly ...
Tags
News
AMRN
Market News
From
Benzinga
Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe
August 04, 2020
From
GlobeNewswire News Releases
Amarin Reports Second Quarter 2020 Financial Results and Provides Update on Operations
August 04, 2020
From
GlobeNewswire News Releases
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
August 02, 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical ...
Tags
JAZZ
GSK
ZGNX
From
Benzinga
AMRN September 11th Options Begin Trading
July 30, 2020
Investors in Amarin Corp plc (AMRN) saw new options begin trading today, for the September 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options...
Tags
Stocks
From
Market News Video
VASCEPA® (icosapent ethyl) Data from REDUCE-IT® REVASC, Including New Data on Timeframe to Demonstrated Benefit, Presented as Encore at The American Society for Preventive Cardiology 2020 Virtual Summ
July 27, 2020
From
GlobeNewswire News Releases
Amarin to Report Second Quarter 2020 Results and Host Conference Call on August 4, 2020
July 21, 2020
From
GlobeNewswire News Releases
Analysts Predict 13% Upside For IBB
July 17, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Here's Why Amarin Tumbled 67.7% in the First Half of 2020
July 08, 2020
The pharma stock collapsed on the threat of generic competition for a drug that launched in December 2019, but the move may have been a bit of an overreaction.
Tags
AMRN
Market News
RDY
From
Motley Fool
Wall Street Has Given Up on These 2 Stocks, and That's a Huge Mistake
July 01, 2020
Why StoneCo and bluebird bio are wonderful buys right now.
Tags
SHOP
NVAX
STNE
From
Motley Fool
Amarin Settlement With Apotex An 'Incremental Positive,' Says Stifel
June 17, 2020
Stifel analyst Derek Archila reiterates his Hold rating on Amarin shares after the company settled with Apotex regarding its ANDA application for generic Vascepa.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Amarin Analysts Say Vascepa Patent Settlement Not A Stock Mover, With 'Little Readthrough For Pending Patent Appeal'
June 17, 2020
Amarin Corporation plc (NASDAQ: AMRN) announced late Tuesday a settlement agreement with Apotex for resolving a patent lawsuit regarding ...
Tags
Derek Archila
News
Stifel
From
Benzinga
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
June 17, 2020
Here's a roundup of top developments in the biotech space over the last 24 hour. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
IDYA
TRIL
Market News
From
Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
June 17, 2020
Gainers Energous Corporation (NASDAQ: WATT) shares rose 126.2% to $5.00 in pre-market trading after the company reported a ...
Tags
Pre/Market Outlook
UONE
MARK
From
Benzinga
Market Briefing For Wednesday, June 17
June 17, 2020
The repeated and projected rallies off the 200-Day Moving Average, would not have been blessed with success if not for favorable news on the COVID-19 front as well as a continually friendly Fed.
Tags
Currencies/Forex
ETFs
Technology
From
Blogs - TalkMarkets
10 Stocks Moving In Tuesday's After-Hours Session
June 16, 2020
Gainers Fulgent Genetics (NASDAQ: FLGT) shares are trading higher after the company announced it launched an at-home testing ...
Tags
GAN
INWK
News
From
Benzinga
Amarin Announces Patent Litigation Settlement Agreement with Apotex Inc.
June 16, 2020
From
GlobeNewswire News Releases
PPH's Holdings Imply 21% Gain Potential
June 16, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
VASCEPA® (icosapent ethyl) Shows Significant Cardiovascular Risk Reduction in People with Diabetes in Prespecified and Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study
June 15, 2020
From
GlobeNewswire News Releases
Amarin Plans to Increase VASCEPA® (icosapent ethyl) Promotion and Education
June 01, 2020
Significant Opportunity Seen as Patient Visits Resume to Emphasize VASCEPA as the First and Only Drug Approved for Its Current Cardiovascular Risk Reduction Indication
From
GlobeNewswire News Releases
What’s Next For The Biotech Bull Market? Are you a Trader or an Investor?
May 26, 2020
Despite the economic pains of the pandemic, investors are driven to life science companies in the news with potential solutions for COVID-19. The potential for a COVID-19 vaccine or a new viral...
Tags
Pharma/Biotech
Mutual Funds
Healthcare
From
Blogs - TalkMarkets
FDA Approves Generic Version of Amarin's Blockbuster Fish Oil Capsules
May 22, 2020
The arrival of a generic version of Vascepa will be bad news for the company.
Tags
RDY
HKMPY
Market News
From
Motley Fool
Generic Threat To Amarin's Vascepa Overrides Positive Sentiment On Coronavirus Announcement
May 22, 2020
Amarin Corporation plc (NASDAQ: AMRN) shares, which were higher in after-hours trading Thursday following the company's announcement ...
Tags
Reiteration
Hikma Biologics
SVB Leerink
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.